News

Addressing Medication Accessibility and Affordability Challenges

Addressing Medication Accessibility and Affordability Challenges

Understanding the Medication Access Landscape

The 2025 Medication Access Report: From Barriers to Bridges, released by CoverMyMeds, underscores a crucial need for collaboration and improved interoperability within the healthcare sector to enhance patient outcomes.

Key Findings of the Report

Among the alarming statistics revealed, a significant 65% of patients have faced delays in obtaining their medications. Additionally, 54% express serious concerns regarding the costs involved with their prescriptions. As this report highlights, medication affordability ranks as the second most crucial consideration for patients after the effectiveness of the drugs.

The Patient Experience

A shocking insight from the report indicates that one in five patients have altered their prescriptions due to cost concerns, while almost as many left pharmacies without their medication after discovering unexpectedly high prices. This presents a troubling picture of the existing barriers faced by patients in the healthcare system.

Fragmentation in the Healthcare System

The ongoing challenges of medication access and affordability are largely attributed to persistent fragmentation among pharmaceutical companies, prescribers, pharmacies, and payers. Over the years, this fragmentation has exacerbated, particularly due to rapidly changing industry dynamics, the emergence of specialty medications, shifts in public policies, and the integration of artificial intelligence (AI). These changes, coupled with the multifaceted needs of patients, have created significant barriers that require urgent attention.

A Call for Action

Kevin Kettler, the President of CoverMyMeds, emphasizes the need for a collective effort to address these challenges. He states, “Patients are ultimately the ones shouldering the burden of the barriers that exist between various healthcare organizations playing a part in their care.” The report serves as an urgent call to action for industry stakeholders to innovate, collaborate, and prioritize patient-centered strategies that transform these barriers into bridges.

Strategies for Improvement

CoverMyMeds has devoted over a decade to deriving insights from industry statistics, market research, patient interviews, and survey data to understand critical barriers hindering patients' access to medications. This annual report aims to empower healthcare professionals with actionable strategies to counter such challenges in the following key areas:

1. Reimagining the Patient Journey

The complexities of the U.S. healthcare system necessitate a rethinking of how the patient journey is defined and supported. The report introduces an emerging approach termed 'Dimensionalization,' which considers the comprehensive spectrum of a patient's experience. This includes not only their medical conditions but also social determinants of health and interactions with various healthcare stakeholders.

2. Enhancing Data Sharing & Interoperability

Effective collaboration and data sharing are essential to tackle the intricate challenges faced in today’s healthcare landscape. However, many of the necessary tools for achieving these goals remain underutilized. The implementation of centralized data systems can facilitate synchronization among stakeholders—from pharmacies to healthcare providers—significantly minimizing discrepancies and ensuring treatment aligns with patient needs.

3. Addressing Drug Pricing Dynamics

Challenges concerning medication affordability are one of the pivotal gaps hindering patients from obtaining necessary medicines. Optimizing workflows and employing integrated care models can help stakeholders improve access to medications. The introduction of responsible AI solutions, educating patients about policies, and promoting at-home administration are just a few strategies detailed in the report.

4. Fostering Patient Engagement and Support Programs

Patient Support Programs (PSPs) play a crucial role in fostering communication and bridging medication access gaps throughout the patient journey. It’s evident that patients prefer digital communication channels with their healthcare providers and expect a seamless, user-friendly experience when engaging with healthcare platforms.

The Research Basis of the Report

Insights in the 2025 Medication Access Report derive from six phases of proprietary research conducted by CoverMyMeds over the past year, which involved 180 qualitative interviews and analysis of 777 quantitative responses from various stakeholders in the healthcare sector.

About CoverMyMeds

CoverMyMeds, now part of McKesson Corporation, is dedicated to enhancing medication access for individuals, helping them obtain the necessary prescriptions to lead healthier lives. By fostering innovation and collaboration, CoverMyMeds aims to seamlessly connect healthcare networks, thereby improving medication access, expediting therapy initiation, and reducing prescription abandonment rates. The company’s extensive network encompasses over 350 electronic health record (EHR) systems, more than 50,000 pharmacies, and almost one million providers across various health plans and pharmacy benefit managers (PBMs).

Frequently Asked Questions

What is the focus of the 2025 Medication Access Report?

The report emphasizes the need for collaboration within the healthcare industry to overcome barriers related to medication access and affordability.

What are some key findings from the report?

Key findings include that 65% of patients face delays in accessing medications, while 54% express concerns about medication costs.

How can healthcare stakeholders improve the patient experience?

By rethinking patient journeys, enhancing data sharing, and fostering patient engagement through support programs.

What does the term 'Dimensionalization' refer to?

Dimensionalization involves understanding a patient's full experience, including social determinants of health and medical interactions, to personalize treatment pathways.

How can patients benefit from the insights in the report?

The report provides actionable strategies that healthcare professionals can utilize to improve patient access to necessary medications and enhance overall healthcare experiences.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 226

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Vector's Peptide Pact Needs Proof Before Any Payday

Updated Category News Views 174

A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...

Continue Reading
Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 116

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
Lummus-Versalis Deal Adds Nine Elastomer Technologies

Updated Category News Views 93

Nine elastomer technologies do not make a flashy headline, yet this is the sort of chemical-industry move that can matter long after the applause dies down. Lummus Technology and Versalis have expanded their partnership to cover nine elastomer technologies. That is the disclosed fact, and it is meaningful on its own. The release does not lay out contract value, duration,...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 62

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading
AMP Tests Debt Market With €1.25 Billion Green Notes

Updated Category News Views 167

Refinancing season has arrived early at Ardagh Metal Packaging, and it is carrying a hefty €1.25 billion price tag. AMP has launched senior secured floating-rate green notes, with proceeds intended to retire two batches of secured debt due in 2028 and leave additional cash on the balance sheet for general corporate purposes, including capital expenditure. This is not...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 49

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
Scenthound’s Franchise Award Spotlights a Real Test

Updated Category News Views 30

A clean dog may not sound like a growth story, yet Scenthound has turned that neglected chore into a surprisingly serious franchise proposition. The company has won the International Franchise Association’s Emerging Franchisor Award after building its dog-hygiene concept from a 2015 founding into a network with more than 180 open locations. That is a respectable piece...

Continue Reading
Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 201

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
BetterInvesting Puts ELMD and FIVE Under a Fresh Lens

Updated Category News Views 74

Two familiar market traps are hiding in this otherwise useful announcement: mistaking a study candidate for a buy signal, and treating the word undervalued like it fell from a mountaintop. BetterInvesting has named Electromed Inc. as its “Stock to Study” and Five Below Inc. as its “Undervalued Stock” for the January-February 2027 issue of its magazine. That is...

Continue Reading

Top 5 Most Recently Viewed Articles

Balaji Srinivasan Links Bitcoin to Wealth and Health Preservation

Updated Category News Views 54

Balaji Srinivasan's Views on Bitcoin's Role Balaji Srinivasan, the former CTO of Coinbase, has been in the spotlight for his insights on how Bitcoin can help protect personal wealth. He draws a compelling comparison between Bitcoin and the pursuit of longevity in healthcare, suggesting both serve as defenses against state control over personal lives. Bitcoin as a Shield...

Continue Reading
Sequana Medical to Host Webinar on alfapump Commercial Launch

Updated Category News Views 213

Sequana Medical's Upcoming KOL Webinar on alfapump Launch Sequana Medical is set to host a Key Opinion Leader (KOL) webinar focused on the alfapump, designed for tackling recurrent and refractory ascites due to liver cirrhosis. This engaging session will take place on January 8. Experts from esteemed institutions will dive into vital discussions about the alfapump's...

Continue Reading
Qualcomm's Strategies to Navigate Competitive Market Pressures

Updated Category News Views 196

Qualcomm's Strong Market Position Despite Challenges Qualcomm Inc (NASDAQ: QCOM) has shown impressive resilience in the market, achieving significant growth largely due to its core chip business, which has seen double-digit growth. This is an encouraging sign of ongoing demand for its technology, particularly with high-end Android devices and innovations within artificial...

Continue Reading
Healthcare Providers Speak: A Study on Challenges and Care

Updated Category News Views 216

Healthcare Providers Speak: A Study on Challenges and Care Shapiro+Raj, a premier insights and strategy consultancy, has unveiled a significant study titled The Provider Perspective: Insights on Policy, Practice, and Patient Care. This comprehensive four-part series delves into the experiences of healthcare providers in the United States, highlighting their readiness to...

Continue Reading
PBOC Executes Groundbreaking Swap Operation of 50 Billion Yuan

Updated Category News Views 101

PBOC's Innovative Swap Operation The People's Bank of China (PBOC) has made waves in the financial sector by executing its very first swap operation involving a remarkable 50 billion yuan, equivalent to approximately 7.03 billion dollars. This pivotal event took place on a Monday, signifying a strategic move in China's monetary policy. Significance of the Swap Operation...

Continue Reading